{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:04:16Z","timestamp":1783937056841,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870404"],"award-info":[{"award-number":["81870404"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["821006487"],"award-info":[{"award-number":["821006487"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515012369"],"award-info":[{"award-number":["2022A1515012369"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010031","name":"Postdoctoral Research Foundation of China","doi-asserted-by":"publisher","award":["2020M683128"],"award-info":[{"award-number":["2020M683128"]}],"id":[{"id":"10.13039\/501100010031","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background\/aims<\/jats:title><jats:p>Nonobese metabolic dysfunction-associated fatty liver disease (MAFLD) is paradoxically associated with improved metabolic and pathological features at diagnosis but similar cardiovascular diseases (CVD) prognosis to obese MAFLD. We aimed to utilize the metabolomics to identify the potential metabolite profiles accounting for this phenomenon.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This prospective multicenter cross-sectional study was conducted in China enrolling derivation and validation cohorts. Liquid chromatography coupled with mass spectrometry and gas chromatography-mass spectrometry were applied to perform a metabolomics measurement.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The study involved 120 MAFLD patients and 60 non-MAFLD controls in the derivation cohort. Controls were divided into two groups according to the presence of carotid atherosclerosis (CAS). The MAFLD group was further divided into nonobese MAFLD with\/without CAS groups and obese MAFLD with\/without CAS groups. Fifty-six metabolites were statistically significant for discriminating the six groups. Among the top 10 metabolites related to CAS in nonobese MAFLD, only phosphatidylethanolamine (PE 20:2\/16:0), phosphatidylglycerol (PG 18:0\/20:4) and de novo lipogenesis (16:0\/18:2n-6) achieved significant areas under the ROC curve (AUCs, 0.67,<jats:italic>p<\/jats:italic>\u2009=\u20090.03; 0.79,<jats:italic>p<\/jats:italic>\u2009=\u20090.02; 0.63,<jats:italic>p<\/jats:italic>\u2009=\u20090.03, respectively). The combination of these three metabolites and liver stiffness achieved a significantly higher AUC (0.92,<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01). In obese MAFLD patients, cystine was found to be significant with an AUC of 0.69 (<jats:italic>p<\/jats:italic>\u2009=\u20090.015), followed by sphingomyelin (SM 16:1\/18:1) (0.71,<jats:italic>p<\/jats:italic>\u2009=\u20090.004) and de novo lipogenesis (16:0\/18:2n-6) (0.73,<jats:italic>p<\/jats:italic>\u2009=\u20090.004). The combination of these three metabolites, liver fat content and age attained a significantly higher AUC of 0.91 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). The AUCs of these metabolites remained highly significant in the independent validation cohorts involving 200 MAFLD patients and 90 controls.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Diagnostic models combining different metabolites according to BMI categories could raise the accuracy of identifying subclinical CAS.<\/jats:p><jats:p><jats:italic>Trial registration<\/jats:italic>The study protocol was approved by the local ethics committee and all the participants have provided written informed consent (Approval number: [2014] No. 112, registered at the Chinese Clinical Trial Registry, ChiCTR-ChiCTR2000034197)<\/jats:p><\/jats:sec><jats:sec><jats:title>Graphical Abstract<\/jats:title><\/jats:sec>","DOI":"10.1186\/s12967-022-03760-6","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T16:04:41Z","timestamp":1673280281000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Metabolomics to identify fingerprints of carotid atherosclerosis in nonobese metabolic dysfunction-associated fatty liver disease"],"prefix":"10.1186","volume":"21","author":[{"given":"Congxiang","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingguang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiting","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3163-4164","authenticated-orcid":false,"given":"Junzhao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8483-6854","authenticated-orcid":false,"given":"Bihui","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,9]]},"reference":[{"issue":"21","key":"3760_CR1","first-page":"01280","volume":"S1542\u20133565","author":"MH Le","year":"2021","unstructured":"Le MH, Yeo YH, Li X, Li J, Zou B, Wu Y, et al. 2019 global NAFLD prevalence: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2021;S1542\u20133565(21):01280\u20135.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3760_CR2","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/hep.30702","volume":"70","author":"F Zhou","year":"2019","unstructured":"Zhou F, Zhou J, Wang W, Zhang XJ, Ji YX, Zhang P, et al. Unexpected rapid increase in the burden of NAFLD in China From 2008 to 2018: a systematic review and meta-analysis. Hepatology. 2019;70:1119\u201333.","journal-title":"Hepatology"},{"key":"3760_CR3","doi-asserted-by":"publisher","first-page":"584396","DOI":"10.3389\/fmed.2020.584396","volume":"7","author":"Y Lin","year":"2021","unstructured":"Lin Y, Gong X, Li X, Shao C, Wu T, Li M, et al. Distinct cause of death profiles of hospitalized non-alcoholic fatty liver disease: a 10 years\u2019 cross-sectional multicenter study in China. Front Med. 2021;7:584396.","journal-title":"Front Med"},{"key":"3760_CR4","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","volume":"65","author":"G Targher","year":"2016","unstructured":"Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol. 2016;65:589\u2013600.","journal-title":"J Hepatol"},{"key":"3760_CR5","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/j.cgh.2020.12.022","volume":"19","author":"H Lee","year":"2021","unstructured":"Lee H, Lee YH, Kim SU, Chang KH. Metabolic dysfunction-associated fatty liver disease and incident cardiovascular disease risk: a Nationwide Cohort Study. Clin Gastroenterol Hepatol. 2021;19:2138\u201347.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3760_CR6","first-page":"e38","volume":"133","author":"D Mozaffarian","year":"2016","unstructured":"Writing Group Members, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 2016;133:e38\u201360.","journal-title":"Circulation"},{"key":"3760_CR7","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12875-020-01306-7","volume":"21","author":"HN Miptah","year":"2020","unstructured":"Miptah HN, Ramli AS, Mohamad M, Hashim H, Tharek Z. Non-alcoholic fatty liver disease (NAFLD) and the cardiovascular disease (CVD) risk categories in primary care: is there an association? BMC Fam Pract. 2020;21:238.","journal-title":"BMC Fam Pract"},{"key":"3760_CR8","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1007\/s10620-019-05926-7","volume":"65","author":"C Shao","year":"2020","unstructured":"Shao C, Ye J, Li F, Lin Y, Wu T, Wang W, et al. Early predictors of cardiovascular disease risk in nonalcoholic fatty liver disease: nonobese versus obese patients. Dig Dis Sci. 2020;65:1850\u201360.","journal-title":"Dig Dis Sci"},{"key":"3760_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/apt.14112","volume":"46","author":"S Sookoian","year":"2017","unstructured":"Sookoian S, Pirola CJ. Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients. Aliment Pharmacol Ther. 2017;46:85\u201395.","journal-title":"Aliment Pharmacol Ther"},{"key":"3760_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/apt.14401","volume":"47","author":"S Sookoian","year":"2018","unstructured":"Sookoian S, Pirola CJ. Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2018;47:16\u201325.","journal-title":"Aliment Pharmacol Ther"},{"key":"3760_CR11","doi-asserted-by":"publisher","first-page":"101092","DOI":"10.1016\/j.molmet.2020.101092","volume":"42","author":"A Deprince","year":"2020","unstructured":"Deprince A, Haas JT, Staels B. Dysregulated lipid metabolism links NAFLD to cardiovascular disease. Mol Metab. 2020;42:101092.","journal-title":"Mol Metab"},{"key":"3760_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cca.2017.08.022","volume":"473","author":"S Qi","year":"2017","unstructured":"Qi S, Xu D, Li Q, Xie N, Xia J, Huo Q, et al. Metabonomics screening of serum identifies pyroglutamate as a diagnostic biomarker for nonalcoholic steatohepatitis. Clin Chim Acta. 2017;473:89\u201395.","journal-title":"Clin Chim Acta"},{"key":"3760_CR13","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.clinbiochem.2016.05.016","volume":"49","author":"Y Chen","year":"2016","unstructured":"Chen Y, Li C, Liu L, Guo F, Li S, Huang L, et al. Serum metabonomics of NAFLD plus T2DM based on liquid chromatography-mass spectrometry. Clin Biochem. 2016;49:962\u20136.","journal-title":"Clin Biochem"},{"key":"3760_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/1354750X.2020.1716073","volume":"25","author":"P McGranaghan","year":"2020","unstructured":"McGranaghan P, Saxena A, Rubens M, Radenkovic J, Bach D, Schleu\u00dfner L, et al. Predictive value of metabolomic biomarkers for cardiovascular disease risk: a systematic review and meta-analysis. Biomarkers. 2020;25:101\u201311.","journal-title":"Biomarkers"},{"key":"3760_CR15","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","volume":"14","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sarin SK, Wong VW, Fan JG, Kawaguchi T, Ahn SH, et al. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int. 2020;14:889\u2013919.","journal-title":"Hepatol Int"},{"key":"3760_CR16","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73:202\u20139.","journal-title":"J Hepatol"},{"key":"3760_CR17","doi-asserted-by":"crossref","first-page":"e13446","DOI":"10.1111\/eci.13446","volume":"51","author":"Q Gu","year":"2020","unstructured":"Gu Q, Cen L, Lai J, Zhang Z, Pan J, Zhao F, et al. A meta-analysis on the diagnostic performance of magnetic resonance imaging and transient elastography in nonalcoholic fatty liver disease. Eur J Clin Investig. 2020;51:e13446.","journal-title":"Eur J Clin Investig"},{"key":"3760_CR18","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.atherosclerosis.2008.07.024","volume":"203","author":"KC Sung","year":"2009","unstructured":"Sung KC, Ryan MC, Wilson AM. The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of nonobese Asian subjects. Atherosclerosis. 2009;203:581\u20136.","journal-title":"Atherosclerosis"},{"key":"3760_CR19","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/jcu.22472","volume":"45","author":"SH Lee","year":"2017","unstructured":"Lee SH, Yun SJ, Kim DH, Jo HH, Park YS. Severity of nonalcoholic fatty liver disease on sonography and risk of coronary heart disease. J Clin Ultrasound. 2017;45:391\u20139.","journal-title":"J Clin Ultrasound"},{"key":"3760_CR20","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.dld.2019.02.019","volume":"51","author":"C Shao","year":"2019","unstructured":"Shao C, Ye J, Li F, Feng S, Wang W, Zhong B. Different predictors of steatosis and fibrosis severity among lean, overweight and obese patients with nonalcoholic fatty liver disease. Dig Liver Dis. 2019;51:1392\u20139.","journal-title":"Dig Liver Dis"},{"key":"3760_CR21","doi-asserted-by":"publisher","first-page":"e111283","DOI":"10.1371\/journal.pone.0111283","volume":"9","author":"Z Dong","year":"2014","unstructured":"Dong Z, Luo Y, Zhang Z, Cai H, Li Y, Chan T, et al. MR quantification of total liver fat in patients with impaired glucose tolerance and healthy subjects. PLoS ONE. 2014;9:e111283.","journal-title":"PLoS ONE"},{"key":"3760_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13098-019-0440-z","volume":"11","author":"J Ye","year":"2019","unstructured":"Ye J, Hu X, Wu T, Wu Y, Shao C, Li F, et al. Insulin resistance exhibits varied metabolic abnormalities in nonalcoholic fatty liver disease, chronic hepatitis B and the combination of the two: a cross-sectional study. Diabetol Metab Syndr. 2019;11:45.","journal-title":"Diabetol Metab Syndr"},{"key":"3760_CR23","doi-asserted-by":"publisher","first-page":"e13446","DOI":"10.1111\/eci.13446","volume":"51","author":"Q Gu","year":"2021","unstructured":"Gu Q, Cen L, Lai J, Zhang Z, Pan J, Zhao F, et al. A meta-analysis on the diagnostic performance of magnetic resonance imaging and transient elastography in nonalcoholic fatty liver disease. Eur J Clin Investig. 2021;51:e13446.","journal-title":"Eur J Clin Investig"},{"key":"3760_CR24","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1159\/000343145","volume":"34","author":"PJ Touboul","year":"2012","unstructured":"Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, et al. Mannheim carotid intima-media thickness and plaque consensus (2004\u20132006\u20132011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis. 2012;34:290\u20136.","journal-title":"Cerebrovasc Dis."},{"key":"3760_CR25","doi-asserted-by":"publisher","first-page":"e00847","DOI":"10.1002\/brb3.847","volume":"7","author":"C Wang","year":"2017","unstructured":"Wang C, Lv G, Zang D. Risk factors of carotid plaque and carotid common artery intima-media thickening in a high-stroke-risk population. Brain Behav. 2017;7:e00847.","journal-title":"Brain Behav"},{"key":"3760_CR26","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3390\/nu10050649","volume":"10","author":"S Tiwari-Heckler","year":"2018","unstructured":"Tiwari-Heckler S, Gan-Schreier H, Stremmel W, Chamulitrat W, Pathil A. Circulating phospholipid patterns in NAFLD patients associated with a combination of metabolic risk factors. Nutrients. 2018;10:649.","journal-title":"Nutrients"},{"key":"3760_CR27","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/hep.28953","volume":"65","author":"Z Hall","year":"2017","unstructured":"Hall Z, Bond NJ, Ashmore T, Sanders F, Ament Z, Wang X, et al. Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease. Hepatology. 2017;65:1165\u201380.","journal-title":"Hepatology"},{"key":"3760_CR28","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1161\/CIRCULATIONAHA.113.002500","volume":"129","author":"C Stegemann","year":"2014","unstructured":"Stegemann C, Pechlaner R, Willeit P, Langley SR, Mangino M, Mayr U, et al. Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study. Circulation. 2014;129:1821\u201331.","journal-title":"Circulation"},{"key":"3760_CR29","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3945\/ajcn.116.137158","volume":"105","author":"AJ Roe","year":"2017","unstructured":"Roe AJ, Zhang S, Bhadelia RA, Johnson EJ, Lichtenstein AH, Rogers GT, et al. Choline and its metabolites are differently associated with cardiometabolic risk factors, history of cardiovascular disease, and MRI-documented cerebrovascular disease in older adults. Am J Clin Nutr. 2017;105:1283\u201390.","journal-title":"Am J Clin Nutr"},{"key":"3760_CR30","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.numecd.2017.07.011","volume":"28","author":"K Paapstel","year":"2018","unstructured":"Paapstel K, Kals J, Eha J, Tootsi K, Ottas A, Piir A, et al. Inverse relations of serum phosphatidylcholines and lysophosphatidylcholines with vascular damage and heart rate in patients with atherosclerosis. Nutr Metab Cardiovasc Dis. 2018;28:44\u201352.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"3760_CR31","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1194\/jlr.RA119000594","volume":"61","author":"G Cadby","year":"2020","unstructured":"Cadby G, Melton PE, McCarthy NS, Giles C, Mellett NA, Huynh K, et al. Heritability of 596 lipid species and genetic correlation with cardiovascular traits in the Busselton Family Heart Study. J Lipid Res. 2020;61:537\u201345.","journal-title":"J Lipid Res"},{"key":"3760_CR32","doi-asserted-by":"publisher","first-page":"891707","DOI":"10.1155\/2015\/891707","volume":"2015","author":"Z Shen","year":"2015","unstructured":"Shen Z, Ye C, McCain K, Greenberg ML. The role of cardiolipin in cardiovascular health. Biomed Res Int. 2015;2015:891707.","journal-title":"Biomed Res Int"},{"key":"3760_CR33","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","volume":"146","author":"JE Lambert","year":"2014","unstructured":"Lambert JE, Ramos-Roman MA, Browning JD, Parks EJ. Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterology. 2014;146:726\u201335.","journal-title":"Gastroenterology"},{"key":"3760_CR34","doi-asserted-by":"publisher","first-page":"e012881","DOI":"10.1161\/JAHA.119.012881","volume":"8","author":"HTM Lai","year":"2019","unstructured":"Lai HTM, de Oliveira Otto MC, Lee Y, Wu JHY, Song X, King IB, et al. Serial plasma phospholipid fatty acids in the de novo lipogenesis pathway and total mortality, cause-specific mortality, and cardiovascular diseases in the cardiovascular health study. J Am Heart Assoc. 2019;8:e012881.","journal-title":"J Am Heart Assoc"},{"key":"3760_CR35","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.atherosclerosis.2019.05.016","volume":"287","author":"GS De Silva","year":"2019","unstructured":"De Silva GS, Desai K, Darwech M, Naim U, Jin X, Adak S, et al. Circulating serum fatty acid synthase is elevated in patients with diabetes and carotid artery stenosis and is LDL-associated. Atherosclerosis. 2019;287:38\u201345.","journal-title":"Atherosclerosis"},{"key":"3760_CR36","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.numecd.2016.03.013","volume":"26","author":"S Haufe","year":"2016","unstructured":"Haufe S, Witt H, Engeli S, Kaminski J, Utz W, Fuhrmann JC, et al. Branched-chain and aromatic amino acids, insulin resistance and liver specific ectopic fat storage in overweight to obese subjects. Nutr Metab Cardiovasc Dis. 2016;26:637\u201342.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"3760_CR37","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1161\/CIRCULATIONAHA.111.067827","volume":"125","author":"S Cheng","year":"2012","unstructured":"Cheng S, Rhee EP, Larson MG, Lewis GD, McCabe EL, Shen D, et al. Metabolite profiling identifies pathways associated with metabolic risk in humans. Circulation. 2012;125:2222\u201331.","journal-title":"Circulation"},{"key":"3760_CR38","doi-asserted-by":"publisher","first-page":"582","DOI":"10.2337\/dc15-2284","volume":"39","author":"CC Lee","year":"2016","unstructured":"Lee CC, Watkins SM, Lorenzo C, Wagenknecht LE, Il\u2019yasova D, Chen YD, et al. Branched-chain amino acids and insulin metabolism: the insulin resistance atherosclerosis study (IRAS). Diabetes Care. 2016;39:582\u20138.","journal-title":"Diabetes Care"},{"key":"3760_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ebiom.2016.10.013","volume":"13","author":"F Zhang","year":"2016","unstructured":"Zhang F, Zhao S, Yan W, Xia Y, Chen X, Wang W, et al. Branched chain amino acids cause liver injury in obese\/diabetic mice by promoting adipocyte lipolysis and inhibiting hepatic autophagy. EBioMedicine. 2016;13:157\u201367.","journal-title":"EBioMedicine"},{"key":"3760_CR40","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/jn\/nxy074","volume":"148","author":"SN Bhupathiraju","year":"2018","unstructured":"Bhupathiraju SN, Guasch-Ferr\u00e9 M, Gadgil MD, Newgard CB, Bain JR, Muehlbauer MJ, et al. Dietary patterns among Asian Indians living in the United States have distinct metabolomic profiles that are associated with cardiometabolic risk. J Nutr. 2018;148:1150\u20139.","journal-title":"J Nutr"},{"key":"3760_CR41","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.molcel.2022.01.021","volume":"82","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Lin S, Peng J, Liang X, Yang Q, Bai X, et al. Amelioration of hepatic steatosis by dietary essential amino acid-induced ubiquitination. Mol Cell. 2022;82:1528\u201342.","journal-title":"Mol Cell"},{"key":"3760_CR42","doi-asserted-by":"publisher","first-page":"e982","DOI":"10.1210\/clinem\/dgaa898","volume":"106","author":"A Lehn-Stefan","year":"2021","unstructured":"Lehn-Stefan A, Peter A, Machann J, Schick F, Randrianarisoa E, Heni M, et al. Elevated circulating Glutamate associates with subclinical atherosclerosis independently of established risk markers: a cross-sectional study. J Clin Endocrinol Metab. 2021;106:e982\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"3760_CR43","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1002\/jum.14494","volume":"37","author":"FH Chen","year":"2018","unstructured":"Chen FH, Liu T, Xu L, Zhang L, Zhou XB. Association of serum vitamin D level and carotid atherosclerosis: a systematic review and meta-analysis. J Ultrasound Med. 2018;37:1293\u2013303.","journal-title":"J Ultrasound Med"},{"key":"3760_CR44","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.3390\/nu6083259","volume":"6","author":"KS Woo","year":"2014","unstructured":"Woo KS, Kwok TC, Celermajer DS. Vegan diet, subnormal vitamin B-12 status and cardiovascular health. Nutrients. 2014;6:3259\u201373.","journal-title":"Nutrients"},{"key":"3760_CR45","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.freeradbiomed.2021.11.027","volume":"178","author":"F Violi","year":"2022","unstructured":"Violi F, Nocella C, Loffredo L, Carnevale R, Pignatelli P. Interventional study with vitamin E in cardiovascular disease and meta-analysis. Free Radic Biol Med. 2022;178:26\u201341.","journal-title":"Free Radic Biol Med"},{"key":"3760_CR46","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3390\/ijms17081328","volume":"17","author":"MA Moser","year":"2016","unstructured":"Moser MA, Chun OK. Vitamin C and heart health: a review based on findings from epidemiologic studies. Int J Mol Sci. 2016;17:1328.","journal-title":"Int J Mol Sci"},{"key":"3760_CR47","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","volume":"28","author":"K Cusi","year":"2022","unstructured":"Cusi K, Isaacs S, Barb D, Basu R, Caprio S, Garvey WT, et al. American Association of Clinical Endocrinology Clinical Practice Guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings: co-sponsored by the American Association for the Study of Liver Diseases (AASLD). Endocr Pract. 2022;28:528\u201362.","journal-title":"Endocr Pract"},{"key":"3760_CR48","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/1751-2980.12685","volume":"20","author":"JG Fan","year":"2019","unstructured":"Fan JG, Wei L, Zhuang H, National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association, Fatty Liver Disease Expert Committee, Chinese Medical Doctor Association. Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China). J Dig Dis. 2019;20:163\u201373.","journal-title":"J Dig Dis"},{"key":"3760_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcmgh.2022.03.006","volume":"14","author":"X Huang","year":"2022","unstructured":"Huang X, Yao Y, Hou X, Wei L, Rao Y, Su Y, et al. Macrophage SCAP contributes to metaflammation and lean NAFLD by activating STING-NF-\u03baB signaling pathway. Cell Mol Gastroenterol Hepatol. 2022;14:1\u201326.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"3760_CR50","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13098-022-00814-z","volume":"14","author":"JK DiStefano","year":"2022","unstructured":"DiStefano JK, Gerhard GS. NAFLD in normal weight individuals. Diabetol Metab Syndr. 2022;14:45.","journal-title":"Diabetol Metab Syndr"},{"key":"3760_CR51","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.cgh.2017.04.045","volume":"15","author":"AL Fracanzani","year":"2017","unstructured":"Fracanzani AL, Petta S, Lombardi R, Pisano G, Russello M, Consonni D, et al. Liver and cardiovascular damage in patients with lean nonalcoholic fatty liver disease, and association with visceral obesity. Clin Gastroenterol Hepatol. 2017;15:1604\u201311.","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03760-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-022-03760-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03760-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T08:35:17Z","timestamp":1701678917000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-022-03760-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,9]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3760"],"URL":"https:\/\/doi.org\/10.1186\/s12967-022-03760-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,9]]},"assertion":[{"value":"30 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the local ethics committee and all the participants have provided written informed consent (Approval number: [2014] No. 112, registered at the Chinese Clinical Trial Registry, ChiCTR-ChiCTR2000034197).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}